Paper2178336
Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.
Zeidner NS and 5 others. Antimicrob Agents Chemother, 1990. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Papers, record 2178336. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2178336
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Feline Acquired Immunodeficiency Syndrome | Major topic |
| Interferon-alpha | Major topic |
| Zidovudine | Major topic |
| Animals | |
| Antibodies | |
| Cats | |
| Drug Therapy, Combination | |
| Injections, Subcutaneous | |
| Interferon alpha-2 | |
| Leukemia Virus, Feline | |
| Recombinant Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N01 AI 72663 | NIAID NIH HHS | United States | N01AI072663 | PubMed and NIH |
Source NIH RePORTER
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10822468 | Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection. | Cancer | 1987 | https://conductscience.org/library/papers/10822468 | PubMed |
| 2 | 1688583 | Natural antibodies to IFN-gamma in man and their increase during viral infection. | J Immunol | 1990 | https://conductscience.org/library/papers/1688583 | PubMed |
| 3 | 191976 | Feline leukemia virus. Its related diseases and control. | Vet Clin North Am | 1977 | https://conductscience.org/library/papers/191976 | PubMed |
| 4 | 6163873 | Convenient assay for interferons. | J Virol | 1981 | https://conductscience.org/library/papers/6163873 | PubMed |
| 5 | 6186744 | Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. | J Immunol Methods | 1983 | https://conductscience.org/library/papers/6186744 | PubMed |
| 6 | 6312876 | Inhibition of feline leukemia virus replication by human leukocyte interferon. | Antiviral Res | 1983 | https://conductscience.org/library/papers/6312876 | PubMed |
| 7 | 6328520 | Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6328520 | PubMed |
| 8 | 2299212 | Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS. | J Infect Dis | 1990 | https://conductscience.org/library/papers/2299212 | PubMed |
| 9 | 2164083 | Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS). | J Acquir Immune Defic Syndr (1988) | 1990 | https://conductscience.org/library/papers/2164083 | PubMed |
| 10 | 6208551 | Remission of leukemia and loss of feline leukemia virus in cats injected with Staphylococcus protein A: association with increased circulating interferon and complement-dependent cytotoxic antibody. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6208551 | PubMed |
| 11 | 2994217 | The epidemiology of AIDS: current status and future prospects. | Science | 1985 | https://conductscience.org/library/papers/2994217 | PubMed |
| 12 | 2413459 | 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/2413459 | PubMed |
| 13 | 3001539 | Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. | Nature | 1986 | https://conductscience.org/library/papers/3001539 | PubMed |
| 14 | 3081245 | The preclinical development of Roferon-A. | Cancer | 1986 | https://conductscience.org/library/papers/3081245 | PubMed |
| 15 | 2427649 | Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS. | J Med Virol | 1986 | https://conductscience.org/library/papers/2427649 | PubMed |
| 16 | 2430286 | Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/2430286 | PubMed |
| 17 | 3099912 | Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. | Br Med J (Clin Res Ed) | 1986 | https://conductscience.org/library/papers/3099912 | PubMed |
| 18 | 3471180 | Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3471180 | PubMed |
| 19 | 3475775 | Characterization of specific immune complexes in HIV-related disorders. | Scand J Immunol | 1987 | https://conductscience.org/library/papers/3475775 | PubMed |
| 20 | 2887929 | Clinical significance of anti-IFN-alpha antibody titres during interferon therapy. | Lancet | 1987 | https://conductscience.org/library/papers/2887929 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39943214 | Recent Issues in the Development and Application of Targeted Therapies with Respect to Individual Animal Variability. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/39943214 | PubMed |
| 31514435 | Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha. | Viruses | 2019 | https://conductscience.org/library/papers/31514435 | PubMed |
| 29061953 | Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus. | Vet Sci | 2015 | https://conductscience.org/library/papers/29061953 | PubMed |
| 29056740 | The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives. | Vet Sci | 2016 | https://conductscience.org/library/papers/29056740 | PubMed |
| 26486979 | Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us? | J Feline Med Surg | 2015 | https://conductscience.org/library/papers/26486979 | PubMed |
| 23321692 | A trial with 3'-azido-2',3'-dideoxythymidine and human interferon-α in cats naturally infected with feline leukaemia virus. | J Feline Med Surg | 2013 | https://conductscience.org/library/papers/23321692 | PubMed |
| 23122808 | Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter. | Res Vet Sci | 2013 | https://conductscience.org/library/papers/23122808 | PubMed |
| 21994560 | Effect of type-I interferon on retroviruses. | Viruses | 2009 | https://conductscience.org/library/papers/21994560 | PubMed |
| 21802033 | Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats. | J Feline Med Surg | 2011 | https://conductscience.org/library/papers/21802033 | PubMed |
| 21719116 | Use of recombinant interferon omega in feline retrovirosis: from theory to practice. | Vet Immunol Immunopathol | 2011 | https://conductscience.org/library/papers/21719116 | PubMed |
| 19481037 | Feline immunodeficiency. ABCD guidelines on prevention and management. | J Feline Med Surg | 2009 | https://conductscience.org/library/papers/19481037 | PubMed |
| 17521745 | Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration. | Vet Immunol Immunopathol | 2007 | https://conductscience.org/library/papers/17521745 | PubMed |
| 17222241 | Feline herpes dermatitis treated with interferon omega. | Vet Dermatol | 2007 | https://conductscience.org/library/papers/17222241 | PubMed |
| 15627627 | Feline infectious peritonitis. | Vet Clin North Am Small Anim Pract | 2005 | https://conductscience.org/library/papers/15627627 | PubMed |
| 7515537 | Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. | Vet Microbiol | 1994 | https://conductscience.org/library/papers/7515537 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2178336
GET https://conductscience.org/api/papers/v1/2178336/references?page=2